Hospitalization Expense of Patients with Rheumatoid Arthritis from Urban Area in China and Its Influential Factors

ZHANG Ye,WU Jing-jing,YANG Li
DOI: https://doi.org/10.6039/j.issn.1001-0408.2013.02.02
2013-01-01
Abstract:OBJECTIVE: To evaluate the hospitalization costs of patients with rheumatoid arthritis (RA) and to predict the influential factors, and to provide reference for the formulation of health policy and the input of health expenditure. METHODS: 349 RA patients were randomly selected by stratified two-stage sampling from China Basic Health Insurance Database in 2009. The demographic characters of patient, clinical diagnosis and costs were collected and analyzed, and the influential factors were predicted by multiple linear regression. RESULTS: Average age of 349 RA patients was (58.9±13.6), among which 73.35% were female. The mean length-of-stay was 17.9 days for urban employees and 15.8 days for urban residents. The average hospitalization cost was 8 521.5 yuan (median: 6 227.5 yuan, IQR: 4 068.9-10 287.3 yuan), and average drug cost was 4 256.9 yuan (median: 3 467.8 yuan, IQR: 1 756.3-5 219.6 yuan), accounting for near of above 50% of hospitalization expense. The multiple linear regressions showed that hospitalization expense of urban employees was higher than that of urban residents by 24.2%(P<0.05); hospitalization expense of patients from eastern region was higher than western region by 26.5%(P<0.05); hospitalization expense of patients treated in three-level hospitals was higher than in primary hospitals by 62.3%(P<0.001); hospitalization expense of patients from first-class cities was higher than from second-class cities and third-class cities by 74.1% and 53.4%, respectively (P<0.001). CONCLUSION: The hospitalization expense of RA patients is very high. Costs are now driven predominantly by drug cost. Main influential factors are types of health insurance, regions, levels of hospitals and levels of cities.
What problem does this paper attempt to address?